مجله علمی پژوهشی سازمان نظام پزشکی
Volume 39, Issue 2 (2021)                   jmciri 2021, 39(2): 73-83 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Guidelines for the Treatment of Pulmonary Artery Hypertension. jmciri 2021; 39 (2) :73-83
URL: http://jmciri.ir/article-1-3076-en.html
Abstract:   (2480 Views)
Pulmonary artery hypertension is a severely debilitating and fatal disease. Unfortunately, despite recent advances in treatment options for this disease, physicians and patients still face many difficulties in using treatment methods and dealing with the problems. During the preparation of this guideline, experienced experts in this field carefully examined the evidences from the reliable sources and an attempt was made to set the recommendations on evidence. Unfortunately, in many cases, there is no accurate evidence to answer the questions that arise in the face of these patients, which is mainly due to the small and heterogeneous number of patients in the studies. Therefore, in cases where there was strong and sufficient evidence based on controlled clinical trials, recommendations were made based on this evidence, and in cases where there was insufficient evidence, the recommendations were based on the collective wisdom of experienced experts in this field and case studies. This guideline is a guide for the treatment of patients with pulmonary artery hypertension (group I) and emphasizes that before starting treatment, the exact diagnosis of the disease and its cause must be determined by experienced specialists in this field
Full-Text [PDF 266 kb]   (1208 Downloads)    
Type of Study: Research | Subject: General

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.